Article Details

180 Life Sciences Secures Patent for Breakthrough Post-Surgery Cognitive Treatment

Retrieved on: 2025-05-01 13:52:05

Tags for this article:

Click the tags to see associated articles and topics

180 Life Sciences Secures Patent for Breakthrough Post-Surgery Cognitive Treatment. View article details on hiswai:

Excerpt

The patent focuses on reducing POCD by administering anti-Human tumor necrosis factor (TNF) Alpha monoclonal antibody during surgical procedures.

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo